Activation specific inhibitors of NF-kB and method of treating inflammatory processes in cardio-vascular diseases
EP1538165A1
Inhibitors of glycoprotein VI based on monoclonal antibody hgp 5c4
EP1462105A1
Activation specific inhibitors of NF-kB and method of treating inflammatory processes in cardio-vascular diseases
EP1477475A1
Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
AU2002338665A1
Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
EP1371723A1
Process for preparing an adenovirus-containing preparation
EP1369128A1
Inhibitors of glycoprotein VI and their therapeutic use
EP1351057A1
Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
EP1336846A1
Method for generating recombinant human platelets for identifying therapeutic target proteins
AU7567901A
Methods and compounds for influencing beta3 integrin-dependent intracellular processes
DE10115073A1
Use of inhibitors of IKK-ß and methods for finding such inhibitors
DE10037272A1
Identifying agents for treating cardiovascular disease, comprises determining the ability of potential agents to modify interaction between beta3 endonexin and beta3 integrin
DE10006889A1
Use of inhibitors of caspase-3 or the caspase-activated deoxyribonuclease (CAD) for the treatment of heart diseases
